Outside advisers to the Food and Drug Administration have voted unanimously to recommend authorization of the Moderna and Pfizer-BioNTech coronavirus vaccines for very young children. Kate Fisher reports that it could clear the way for regulators to authorize both long-awaited pediatric vaccines on an emergency basis later this week.